Data analysis, clinical biostatistics and more.
Company founded in
Percent employees with university degree
Our team members are experts in biostatistics. Beyond that, we are experienced in project work, working on different infrastructures and with complex processes.
Staburo Client Segments
- Biotech, Medical Device companies, etc.
Temporally and spatially flexible
Experienced in pharma processes
Check out our latest news!
Staburo @ Joint EFSPI / BBS Webinar: Estimands addendum is final: Anything new for oncology? We are very proud that Staburo's Managing Director Dr. Hannes Buchner will be a speaker and will talk about "Treatment switching: challenges, estimands, and estimators". All...
How to Avoid Overfitting, Precision Medicine in Action & Tumour Growth Modelling – three PSI contributions
Staburo's 2020 PSI contributions in webinar format on 26 May (15:00 – 17:15 CET) Since the 2020 PSI conference will unfortunately not take place, we decided to share our PSI contributions in an online live webinar with our colleagues. Staburo biostatisticians Nicole...
Staburo supported evaluation of medical device which got FDA Emergency Use Authorization for COVID-19
Staburo supported evaluation of medical device which recently got FDA Emergency Use Authorization for COVID-19Staburo Managing Director Dr. Hannes Buchner and our team was involved in statistical consulting and performing data analysis in a trial for a medical device...